Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Non-Hodgkin × Granulocyte-Macrophage Colony-Stimulating Factor × 1 year × Clear all

Sponsor

Conditions

Neuroblastoma 10 Brain Neoplasms 3 Recurrence 2 Osteosarcoma 2 Medulloblastoma 2 Leukemia, Myeloid, Acute 2 Glioma 2 Glioblastoma 2 Diffuse Intrinsic Pontine Glioma 2 Xanthomatosis, Cerebrotendinous 1 Wilms Tumor 1 Uveal Melanoma 1 Transplant-Related Hematologic Malignancy 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Resectable Esophageal Cancer 1 Pathologic Complete Response 1 Oligodendroglioma 1 Neoplasms 1 Multiple Myeloma 1 Mesothelioma, Malignant 1 Mesothelioma 1 Melanoma 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Leukemia 1 Influenza, Human 1 Hodgkin Disease 1

Interventions

Cyclophosphamide 58 Rituximab 47 fludarabine 38 fludarabine phosphate 25 obinutuzumab 17 venetoclax 16 Lenalidomide 16 ibrutinib 15 Etoposide 14 Prednisone 13 pirtobrutinib 12 Whole-Body Irradiation 12 Mycophenolic Acid 11 Melphalan 11 Bendamustine Hydrochloride 11 Tacrolimus 10 Specimen Handling 10 Filgrastim 10 Doxorubicin 10 Biopsy 10 Vincristine 9 Magnetic Resonance Spectroscopy 9 Granulocyte Colony-Stimulating Factor 9 pembrolizumab 8 Stem Cell Transplantation 8 Peripheral Blood Stem Cell Transplantation 8 Nivolumab 8 Gemcitabine 8 Cytarabine 8 tocilizumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡